Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD
Public ClinicalTrials.gov record NCT03638466. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Exploratory Neuroimaging Study to Evaluate the Effect on Brain Activity of SPN-810 for Impulsive Aggression (IA) in Patients With Attention-Deficit/Hyperactivity Disorder (ADHD) in Conjunction With Standard ADHD Treatment
Study identification
- NCT ID
- NCT03638466
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Supernus Pharmaceuticals, Inc.
- Industry
- Enrollment
- 7 participants
Conditions and interventions
Interventions
- Functional Magnetic Resonance Imaging (fMRI) Diagnostic Test
- Magnetic Resonance Spectroscopy (MRS) Diagnostic Test
- Point Subtraction Aggression Paradigm (PSAP) Task Behavioral
- SPN-810 Drug
- Placebo Drug
Diagnostic Test · Behavioral · Drug
Eligibility (public fields only)
- Age range
- 8 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 29, 2019
- Primary completion
- Nov 6, 2019
- Completion
- Nov 6, 2019
- Last update posted
- May 1, 2025
2019
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Meridien Research aka Florida Clinical Research Center, LLC | Lakeland | Florida | 33805 | — |
| Florida Clinical Research Center, LLC. | Maitland | Florida | 32751 | — |
| University of South Florida- Dept. of Psychiatry and Neurosciences | Tampa | Florida | 33613 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03638466, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 1, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03638466 live on ClinicalTrials.gov.